. 2015 Jan 22;56(2):346–353. doi: 10.1093/jrr/rru115

Table 3.

Correlation between total EQD₂ dose and tumor control according to FIGO stage

		FIGO	n	Mean EQD₂	Median EQD₂	Range	Percent recurrence (number)
				(Gy_α/β10)	(Gy_α/β10)		Percent recurrence (number)
Primary	Overall			65	70	38–96	18	(9/49)
		I	20	57	57	38–80	5	(1/20)
		II	19	70	70	53–96	16	(3/19)
		III–IV	10	73	79	44–90	50	(5/10)
Gross node	Overall		15	56	60	44–66	27	(4/15^a)
Prophylactic	Overall			39	50	0–60	22	(11/49)
		I^b	8	0	0	0	38	(3/8)
		I	12	46	50	30–50	17	(2/12)
		II	19	47	50	30–60	11	(2/19)
		III–IV	10	49	50	40–60	40	(4/10)

^aAll four cases with recurrence received a total dose of 50 Gy or less. ^bProphylactic lymph node irradiation was not performed. EQD₂ = equivalent dose in 2-Gy fractions, FIGO = Federation of Gynecology and Obstetrics.